Join to View Full Profile
1959 Ne Pacific StSeattle, WA 98195
Phone+1 206-598-4294
Dr. Schade is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. George Schade is a Seattle-based urologist specializing in minimally invasive surgery and surgical oncology. His education includes an internship and residency at the University of Michigan Health System, followed by a fellowship in minimally invasive urologic surgery at the University of Washington School of Medicine. Currently, he serves as an Associate Professor at UW Medicine/University of Washington Medical Center. His expertise covers urologic oncology, robotic surgeries, and specialized techniques like high-intensity focused ultrasound. Dr. Schade has published multiple research articles in peer-reviewed journals and conducted clinical trials, notably on pain management post-radical cystectomy. He is also recognized as a Research Scholar by the Urology Care Foundation.
Education & Training
University of Washington School of MedicineFellowship, Minimally Invasive Urologic Surgery, 2013 - 2015
University of MichiganResidency, Urology, 2008 - 2013- University of Michigan Health SystemInternship, Transitional Year, 2007 - 2008
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007
University of ChicagoBA, Biology, General Honors, 1999 - 2003
Certifications & Licensure
WA State Medical License 2013 - 2027
MI State Medical License 2007 - 2013
American Board of Urology Urology
Awards, Honors, & Recognition
- Research Scholar Urology Care Foundation, 2015
Clinical Trials
- Gabapentin in Reducing the Need for Pain Medication in Patients With Bladder Cancer Undergoing Radical Cystectomy Start of enrollment: 2015 Apr 22
Publications & Presentations
PubMed
- 3 citationsNew kids on the block: MRI guided transrectal focused US, TULSA, focal laser ablation, histotripsy - a comprehensive review.Sangeet Ghai, Tiffany T Ni, Christian P Pavlovich, Jurgen J Futterer, George R Schade
Prostate Cancer and Prostatic Diseases. 2026-03-01 - Doppler-based assessment of boiling histotripsy-induced volumetric tissue liquefaction in vivo.Minho Song, Gilles P L Thomas, Vera A Khokhlova, Yak-Nam Wang, Stephanie I Totten
Ultrasonics. 2025-12-01 - Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort s...Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, Leonidas Ν Diamantopoulos, Dimitrios Makrakis
Urologic Oncology. 2025-12-01
Authored Content
- Does the Diagnosis of Bladder Cancer Lead to Higher Rates of Smoking Cessation? Findings from the Medicare Health Outcomes SurveyMarch 2019
Press Mentions
What 5 Doctors Are Excited About in Kidney Cancer ResearchSeptember 5th, 2024- EDAP Announces University of Washington Medicine to Launch Focal One® Robotic HIFU ProgramSeptember 28th, 2021
Grant Support
- Transrectal Histotripsy for Focal Ablation of Prostate CancerUNIVERSITY OF WASHINGTON2022–2027
- Noninvasive histotripsy ablation of fibrotic tissue in benign prostatic hyperplasiaUNIVERSITY OF WASHINGTON2019–2025
- Strategies in therapeutic ultrasound for predicting in situ fields and quantifying the impact of tissue inhomogeneitiesNIBIB2018–2021
- Metrology and Nonlinear Acoustics Bioeffects of High Intensity Focused UltrasoundNIBIB2017–2021
- FOCAL THERAPY OF PROSTATE CANCER USING NON-THERMAL TUMOR ABLATION WITH FOCUSED ULTRASOUNDNCI2017–2020
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
